Novo Nordisk collaborating with Mayo Clinic in diabetes disease state management.
NOVO NORDISK/MAYO CLINIC COLLABORATING IN DIABETES PROGRAM designed to improve the management of Type I and Type II diabetes. Novo is providing an undisclosed amount to fund an international diabetes research training center at the Mayo Clinic in Rochester, Minn. and to fund a clinical project involving electronic data recording. Mayo is providing personnel and expertise.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth